Title : Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?

Pub. Date : 2011 Mar 1

PMID : 20919927






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The anti-Parkinsonian, monoamine oxidase-B inhibitor drug, rasagiline (Azilect ), is primarily metabolized by hepatic cytochrome P450 isoenzyme 1A2-mediated N-dealkylation to form its major metabolite, 1-(R)-aminoindan. rasagiline monoamine oxidase B Rattus norvegicus
2 The anti-Parkinsonian, monoamine oxidase-B inhibitor drug, rasagiline (Azilect ), is primarily metabolized by hepatic cytochrome P450 isoenzyme 1A2-mediated N-dealkylation to form its major metabolite, 1-(R)-aminoindan. rasagiline monoamine oxidase B Rattus norvegicus